0001062993-22-008073.txt : 20220317 0001062993-22-008073.hdr.sgml : 20220317 20220317173308 ACCESSION NUMBER: 0001062993-22-008073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENLOE J DAVID JR CENTRAL INDEX KEY: 0001201526 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 22750037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 770-534-8239 MAIL ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-03-15 0001588972 Recro Pharma, Inc. REPH 0001201526 ENLOE J DAVID JR C/O RECRO PHARMA, INC. 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 1 1 0 0 Chief Executive Officer Common Stock 2022-03-15 4 P 0 512 1.96 A 524879 D This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Ryan D Lake, attorney-in-fact 2022-03-17